These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26759836)

  • 41. The enolization chemistry of a thioester-dependent racemase: the 1.4 Å crystal structure of a reaction intermediate complex characterized by detailed QM/MM calculations.
    Sharma S; Bhaumik P; Schmitz W; Venkatesan R; Hiltunen JK; Conzelmann E; Juffer AH; Wierenga RK
    J Phys Chem B; 2012 Mar; 116(11):3619-29. PubMed ID: 22360758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-methylacyl coenzyme A racemase as a marker for prostate cancer.
    Jiang Z; Woda BA; Yang XJ
    JAMA; 2002 Jun; 287(23):3080-1; author reply 3081. PubMed ID: 12069667
    [No Abstract]   [Full Text] [Related]  

  • 43. α-Methylacyl-CoA Racemase from
    Mojanaga OO; Woodman TJ; Lloyd MD; Acharya KR
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitors.
    Morgenroth A; Urusova EA; Dinger C; Al-Momani E; Kull T; Glatting G; Frauendorf H; Jahn O; Mottaghy FM; Reske SN; Zlatopolskiy BD
    Chemistry; 2011 Aug; 17(36):10144-50. PubMed ID: 21812041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of alpha methylacyl-coenzyme A racemase in differentiating hepatocellular carcinoma from dysplastic and nondysplastic liver cell lesions.
    Helal Tel A; Radwan NA; Abdel Kader Z; Helmy NA; Hammad SY
    Ann Diagn Pathol; 2012 Oct; 16(5):330-4. PubMed ID: 22542076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure of mycobacterial β-oxidation trifunctional enzyme reveals its altered assembly and putative substrate channeling pathway.
    Venkatesan R; Wierenga RK
    ACS Chem Biol; 2013 May; 8(5):1063-73. PubMed ID: 23496842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.
    Dixon SM; Li P; Liu R; Wolosker H; Lam KS; Kurth MJ; Toney MD
    J Med Chem; 2006 Apr; 49(8):2388-97. PubMed ID: 16610782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approach.
    Pauli I; dos Santos RN; Rostirolla DC; Martinelli LK; Ducati RG; Timmers LF; Basso LA; Santos DS; Guido RV; Andricopulo AD; Norberto de Souza O
    J Chem Inf Model; 2013 Sep; 53(9):2390-401. PubMed ID: 23889525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha-methylacyl-CoA racemase is expressed in a majority of pancreatic neoplasms of neuroendocrine, acinar, and solid pseudopapillary differentiation.
    Liszka Ł
    Pathology; 2015 Aug; 47(5):466-8. PubMed ID: 26126032
    [No Abstract]   [Full Text] [Related]  

  • 51. Overexpression of α-methylacyl-CoA racemase is associated with CTNNB1 mutations in hepatocellular carcinomas.
    Sekine S; Ogawa R; Ojima H; Kanai Y
    Histopathology; 2011 Apr; 58(5):712-9. PubMed ID: 21457159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues.
    van Straaten KE; Kuttiyatveetil JR; Sevrain CM; Villaume SA; Jiménez-Barbero J; Linclau B; Vincent SP; Sanders DA
    J Am Chem Soc; 2015 Jan; 137(3):1230-44. PubMed ID: 25562380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of Allosteric and Selective Inhibitors of Inorganic Pyrophosphatase from Mycobacterium tuberculosis.
    Pang AH; Garzan A; Larsen MJ; McQuade TJ; Garneau-Tsodikova S; Tsodikov OV
    ACS Chem Biol; 2016 Nov; 11(11):3084-3092. PubMed ID: 27622287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-based virtual screening and biological evaluation of Mycobacterium tuberculosis adenosine 5'-phosphosulfate reductase inhibitors.
    Cosconati S; Hong JA; Novellino E; Carroll KS; Goodsell DS; Olson AJ
    J Med Chem; 2008 Nov; 51(21):6627-30. PubMed ID: 18855373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target.
    Beato C; Pecchini C; Cocconcelli C; Campanini B; Marchetti M; Pieroni M; Mozzarelli A; Costantino G
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):645-52. PubMed ID: 26133542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and enzyme inhibitory activity of the s-nucleoside analogue of the ribitylaminopyrimidine substrate of lumazine synthase and product of riboflavin synthase.
    Talukdar A; Illarionov B; Bacher A; Fischer M; Cushman M
    J Org Chem; 2007 Sep; 72(19):7167-75. PubMed ID: 17696548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does alpha-methylacyl-CoA-racemase play an important role in perineural tumor invasion?
    Sen Gupta R
    Hum Pathol; 2007 Aug; 38(8):1289-90; author reply 1290-1. PubMed ID: 17640555
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition of glutamate racemase by substrate-product analogues.
    Pal M; Bearne SL
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1432-6. PubMed ID: 24507924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The substrate capture mechanism of Mycobacterium tuberculosis anthranilate phosphoribosyltransferase provides a mode for inhibition.
    Castell A; Short FL; Evans GL; Cookson TV; Bulloch EM; Joseph DD; Lee CE; Parker EJ; Baker EN; Lott JS
    Biochemistry; 2013 Mar; 52(10):1776-87. PubMed ID: 23363292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new strategy to decrease N-methyl-D-aspartate (NMDA) receptor coactivation: inhibition of D-serine synthesis by converting serine racemase into an eliminase.
    Panizzutti R; De Miranda J; Ribeiro CS; Engelender S; Wolosker H
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5294-9. PubMed ID: 11309496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.